KRT19 and breast carcinoma: Previous studies have shown that MCF-7 breast cancer cells do not typically express VIM but exhibit strong expression of KRT; the acquisition of VIM expression and the loss of KRT19 expression were associated with adriamycin-resistant MCF-7 cells compared with their parental cells [11].